Phase ii study to evaluate the clinical. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Esophagogastric Junction Monocytes, Activated Killer

Organisms1

Diseases82

Leukopenia Neutropenia Lung Neoplasms Neoplasm Metastasis Neoplasm Recurrence, Local Carcinoma, Non-Small-Cell Lung Disease Progression Nausea Thrombocytopenia Adenocarcinoma Breast Neoplasms Stomach Neoplasms Colorectal Neoplasms Brain Neoplasms Hematologic Diseases Vomiting Peritoneal Neoplasms Biliary Tract Neoplasms Carcinoma, Small Cell Ovarian Neoplasms Sarcoma Neoplasms Mesothelioma Diarrhea Pleural Neoplasms Carcinoma, Squamous Cell Pancreatic Neoplasms Liver Neoplasms Kidney Neoplasms Melanoma Recurrence Stomatitis Carcinoma, Renal Cell Asthenia Lymphoma, Non-Hodgkin Brain Stem Neoplasms Glioblastoma Urologic Neoplasms Fatigue Carcinoma Anorexia Alopecia Rectal Neoplasms Glioma Prostatic Neoplasms Anemia Esophageal Neoplasms Drug-Related Side Effects and Adverse Reactions Small Cell Lung Carcinoma Soft Tissue Neoplasms Bone Neoplasms Carcinoma, Transitional Cell Fallopian Tube Neoplasms Carcinoma, Large Cell Head and Neck Neoplasms Gallbladder Neoplasms Drug Eruptions Neoplasms, Glandular and Epithelial Supratentorial Neoplasms Vomiting, Anticipatory Nasopharyngitis Exanthema Lymphoma, Mantle-Cell Agranulocytosis Leiomyosarcoma Astrocytoma Lymphatic Metastasis Oligodendroglioma Neuroendocrine Tumors Gastrointestinal Neoplasms Nasopharyngeal Neoplasms Skin Neoplasms Gastrointestinal Diseases Peripheral Nervous System Diseases Mucositis Lymphoma, Follicular Neoplasms, Hormone-Dependent Leukemia, Lymphocytic, Chronic, B-Cell Fever Myelodysplastic Syndromes Neoplasms, Unknown Primary Adenocarcinoma, Bronchiolo-Alveolar

Chemicals and Drugs100

Deoxycytidine Cisplatin Taxoids Fluorouracil Antineoplastic Agents Paclitaxel Organoplatinum Compounds Camptothecin Antineoplastic Agents, Phytogenic Carboplatin Leucovorin Antimetabolites, Antineoplastic Vinblastine Antibodies, Monoclonal, Humanized Dacarbazine Tegafur Quinazolines Oxonic Acid Etoposide Antineoplastic Agents, Alkylating Doxorubicin Epirubicin Bridged Compounds Benzenesulfonates Phenylurea Compounds Niacinamide Antibodies, Monoclonal Ifosfamide Epothilones Cyclophosphamide Anthracyclines Topotecan Estramustine Vincristine Granulocyte Colony-Stimulating Factor Thalidomide Pyrroles Pyrazines Angiogenesis Inhibitors Pyridines Antibodies, Monoclonal, Murine-Derived Platinum Compounds Boronic Acids Guanine Uracil Protein Kinase Inhibitors Pyrimidines Mitomycin Drug Combinations Indoles Antibiotics, Antineoplastic Mitoxantrone Glutamates Prednisone Nitrogen Mustard Compounds Depsipeptides Prostate-Specific Antigen Platinum Thiophenes Benzamides Arabinonucleosides Dioxolanes Sulfonamides Vidarabine Phosphate Amifostine Recombinant Proteins Mesna Tumor Markers, Biological Pentostatin Lomustine Methotrexate Vindesine Dexamethasone Procarbazine Receptor, Epidermal Growth Factor Interferon-alpha Pyrazoles Floxuridine Piperazines Dioxoles Polyethylene Glycols Cytarabine Topoisomerase I Inhibitors Receptor, erbB-2 Tetrahydroisoquinolines Antineoplastic Agents, Hormonal Indazoles Piperidines Receptors, Vascular Endothelial Growth Factor Placebos Biomarkers, Pharmacological Vidarabine Hydroxyethylrutoside Cladribine Sirolimus Maytansine Trimetrexate Melphalan Farnesyltranstransferase Snake Venoms

Analytical, Diagnostic and Therapeutic Techniques and Equipment59

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Clinical Trials, Phase II as Topic Treatment Outcome Infusions, Intravenous Disease-Free Survival Drug Evaluation Survival Analysis Survival Rate Maximum Tolerated Dose Neoplasm Staging Salvage Therapy Administration, Oral Combined Modality Therapy Kaplan-Meier Estimate Remission Induction Neoadjuvant Therapy Clinical Trials, Phase III as Topic Follow-Up Studies Feasibility Studies Treatment Failure Chemotherapy, Adjuvant Clinical Trials, Phase I as Topic Prospective Studies Prognosis Area Under Curve Injections, Subcutaneous Injections, Intravenous Chemoradiotherapy Endpoint Determination Induction Chemotherapy Double-Blind Method Radiotherapy, Adjuvant Dose Fractionation Radiotherapy, High-Energy Pilot Projects Clinical Trials as Topic Research Design Radiotherapy Dosage Infusions, Intra-Arterial Palliative Care Drug Therapy, Combination Probability Chronotherapy Patient Selection Transplantation, Autologous Karnofsky Performance Status Administration, Intravenous Orchiectomy Placebos Early Termination of Clinical Trials Retreatment Multicenter Studies as Topic Infusions, Spinal Confidence Intervals Risk Assessment Radioimmunotherapy Infusions, Parenteral Hematopoietic Stem Cell Transplantation

Phenomena and Processes7

Maximum Tolerated Dose Dose-Response Relationship, Drug Metabolic Detoxication, Phase II Drug Resistance, Neoplasm Time Factors Area Under Curve Probability

Disciplines and Occupations1

Research Design

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Technology, Industry, Agriculture1

Polyethylene Glycols

Humanities1

Quality of Life

Information Science1

Health Care25

Clinical Trials, Phase II as Topic Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Kaplan-Meier Estimate Clinical Trials, Phase III as Topic Follow-Up Studies Feasibility Studies Treatment Failure Clinical Trials, Phase I as Topic Prospective Studies Area Under Curve Safety Double-Blind Method Pilot Projects Clinical Trials as Topic Palliative Care Probability Patient Selection Karnofsky Performance Status Early Termination of Clinical Trials Multicenter Studies as Topic Confidence Intervals Risk Assessment

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Clinical Trials, Phase II as Topic Treatment Outcome Infusions, Intravenous Deoxycytidine Cisplatin Taxoids Disease-Free Survival Fluorouracil Antineoplastic Agents Drug Evaluation Paclitaxel Organoplatinum Compounds Camptothecin Survival Analysis Leukopenia Neutropenia Lung Neoplasms Survival Rate Antineoplastic Agents, Phytogenic Neoplasm Metastasis Maximum Tolerated Dose Carboplatin Neoplasm Recurrence, Local Neoplasm Staging Leucovorin Salvage Therapy Antimetabolites, Antineoplastic Vinblastine Carcinoma, Non-Small-Cell Lung Administration, Oral Disease Progression Dose-Response Relationship, Drug Antibodies, Monoclonal, Humanized Combined Modality Therapy Nausea Dacarbazine Tegafur Thrombocytopenia Quinazolines Oxonic Acid Metabolic Detoxication, Phase II Etoposide Kaplan-Meier Estimate Adenocarcinoma Antineoplastic Agents, Alkylating Doxorubicin Remission Induction Drug Resistance, Neoplasm Epirubicin Bridged Compounds Benzenesulfonates Phenylurea Compounds Niacinamide Antibodies, Monoclonal Ifosfamide Breast Neoplasms Stomach Neoplasms Colorectal Neoplasms Brain Neoplasms Hematologic Diseases Epothilones Vomiting Neoadjuvant Therapy Clinical Trials, Phase III as Topic Peritoneal Neoplasms Biliary Tract Neoplasms Cyclophosphamide Carcinoma, Small Cell Follow-Up Studies Anthracyclines Feasibility Studies Ovarian Neoplasms Topotecan Sarcoma Neoplasms Estramustine Vincristine Granulocyte Colony-Stimulating Factor Mesothelioma Diarrhea Pleural Neoplasms Treatment Failure Time Factors Thalidomide Carcinoma, Squamous Cell Pancreatic Neoplasms Liver Neoplasms Kidney Neoplasms Melanoma Recurrence Chemotherapy, Adjuvant Clinical Trials, Phase I as Topic Prospective Studies Stomatitis Pyrroles Pyrazines Carcinoma, Renal Cell Angiogenesis Inhibitors

No FAQ available that match "phase ii study to evaluate the clinical"